Acme United Q3 sales rise, helped by strong first aid sales

Acme United

21/10/2025 11:39

Overview

Acme United Q3 sales rose 2% yr/yr but missed analyst expectations

Net income for Q3 fell 14% due to higher tax rate

Company's first aid revenues increased 9% amid strong online and refill sales

Outlook

Acme United is experiencing increased promotional activity

Company continues to manage through tariff-related uncertainties

Result Drivers

FIRST AID SALES - Strong online and refill sales boosted first aid revenues by 9%

TARIFF IMPACT - Tariff environment led to reduced sales of Westcott cutting tools and cancellation of retail promotions

OPERATING INCOME - Operating income increased 3% despite challenges, supported by effective management

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Miss
$49.06 mln
$50.70 mln (2 Analysts)
Q3 Net Income
$1.9 mln
Q3 Basic EPS
$0.50
Q3 Gross Profit
$19.19 mln
Q3 Operating Income
$3 mln
Q3 Pretax Profit
$2.43 mln


Analyst Coverage

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for Acme United Corp is $50.50, about 23.9% above its October 20 closing price of $38.45

The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nGNXb4NXGl

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)